Faccenda, V.; Colciago, R.R.; Bianchi, S.P.; De Ponti, E.; Panizza, D.; Arcangeli, S.
Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases. Cancers 2024, 16, 3243.
https://doi.org/10.3390/cancers16183243
AMA Style
Faccenda V, Colciago RR, Bianchi SP, De Ponti E, Panizza D, Arcangeli S.
Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases. Cancers. 2024; 16(18):3243.
https://doi.org/10.3390/cancers16183243
Chicago/Turabian Style
Faccenda, Valeria, Riccardo Ray Colciago, Sofia Paola Bianchi, Elena De Ponti, Denis Panizza, and Stefano Arcangeli.
2024. "Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases" Cancers 16, no. 18: 3243.
https://doi.org/10.3390/cancers16183243
APA Style
Faccenda, V., Colciago, R. R., Bianchi, S. P., De Ponti, E., Panizza, D., & Arcangeli, S.
(2024). Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases. Cancers, 16(18), 3243.
https://doi.org/10.3390/cancers16183243